Director, EHSS Audit & Assurance at Bristol-Myers Squibb

Lawrence Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor’s degree in life sciences, engineering, or a related field; advanced degrees preferred
Minimum 10 years of EHSS experience, with significant leadership in audit program development and delivery
Deep knowledge of EHSS management systems (ISO14001, ISO45001, PSM) and global regulatory frameworks
Proven ability to lead global audit teams and communicate findings to diverse audiences
Experience with digital audit tools, data analytics, and AI integration in compliance programs
Strong project management, stakeholder engagement, and change leadership skills
Willingness to travel up to 50% globally and work flexibly across varied environments
Preferred: Professional certifications (CIH, CSP); ISO 14001/45001 Lead Auditor credential

Responsibilities

Lead the global EHSS internal audit program, including strategic planning, scoping, execution, and reporting, aligned with internal standards and business priorities
Oversee annual audit goal-setting, long-range planning, and outcome reporting to senior leadership; support management review and trend analysis
Drive continuous improvement of audit processes by analyzing findings, identifying systemic risks, and recommending enhancements to EHSS programs and controls
Advance digitalization of the audit program, including integration of AI and analytics to improve efficiency, insight generation, and risk prediction
Develop and deliver auditor training and communications, partnering with site leaders, EHSS systems leads, and external providers
Serve as the primary liaison for internal and external audit stakeholders, including certification bodies and industry organizations
Provide expert guidance in complex EHSS scenarios, applying risk-based thinking and cross-functional collaboration

Skills

EHSS Audit

Internal Audit

Risk Management

Compliance Assurance

Audit Planning

Strategic Planning

Stakeholder Management

Trend Analysis

Digital Innovation

Systems Thinking

Governance

Continuous Improvement

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free